Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Humacyte Inc., 3 years.
Humacyte Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Humacyte Inc. June 9, 202684.7%
-
Humacyte Inc. June 7, 202391.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 19, 2026 | Humacyte Inc. | Open-market purchase | +56,818 | $0.88 | $50,000 |
| Apr 8, 2025 | Humacyte Inc. | Open-market purchase | +50,000 | $1.32 | $66,000 |
| Sep 10, 2024 | Humacyte Inc. | Option exercise | +4,521 | $4.34 | $19,621 |
| Sep 10, 2024 | Humacyte Inc. | Open-market sale | −3,634 | $5.41 | $19,660 |
| Sep 10, 2024 | Humacyte Inc. | Option exercise | +2,479 | $3.35 | $8,305 |
| Sep 10, 2024 | Humacyte Inc. | Open-market sale | −1,548 | $5.39 | $8,344 |
| Jun 14, 2024 | Humacyte Inc. | Option exercise | +39,389 | $2.56 | $100,836 |
Questions about Kathleen Sebelius
What boards is Kathleen Sebelius on?
Kathleen Sebelius sits on the board of Humacyte Inc.
How long has Kathleen Sebelius served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.